Kailera Therapeutics is trading 4.99% up at $13.47, with the move appearing aligned with broader risk-on sentiment; no fresh company-specific announcement was identified for September 21, 2026.
- Major U.S. indices are higher in pre-market trading.
- Firmer Asian equities and a dovish interpretation of the Bank of Japan’s rate increase are supporting global equities.
- The next scheduled investor events are September 23 and September 30.